ESMO OPEN

Publications

  1. 2024
  2. Estimating the prevalence of mental disorders in patients with newly diagnosed cancer in relation to socioeconomic status: a multi-center prospective observational study

    Goerling, U., Ernst, J., Esser, P., Haering, C., Hermann, M., Hornemann, B., Hövel, P., Keilholz, U., Kissane, D., von dem Knesebeck, O., Lordick, F., Springer, F., Zingler, H., Zimmermann, T., Engel, C. & Mehnert-Theuerkauf, A., 08.2024, In: ESMO OPEN. 9, 8, p. 103655 103655.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Efficacy and safety of high-dose chemotherapy as the first or subsequent salvage treatment line in patients with relapsed or refractory germ cell cancer: an international multicentric analysis

    Seidel, C., Schaefers, C., Connolly, E. A., Weickhardt, A., Grimison, P., Wong, V., De Giorgi, U., Hentrich, M., Zschäbitz, S., Ochsenreither, S., Vincenzi, B., Oing, C., Bokemeyer, C., Engel, N., Alsdorf, W. & Tran, B., 05.2024, In: ESMO OPEN. 9, 5, p. 103449

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. 2023
  5. Young oncologists' perspective on the role and future of the clinician-scientist in oncology

    Lim, K. H. J., Westphalen, C. B., Berghoff, A. S., Cardone, C., Connolly, E. A., Güven, D. C., Kfoury, M., Kocakavuk, E., Mandó, P., Mariamidze, E., Matikas, A., Moutafi, M., Oing, C., Pihlak, R., Punie, K., Sánchez-Bayona, R., Sobczuk, P., Starzer, A. M., Tečić Vuger, A., Zhu, H., Cruz-Ordinario, M. V. B., Altuna, S. C., Canário, R., Vuylsteke, P., Banerjee, S., de Azambuja, E., Cervantes, A., Lambertini, M., Mateo, J. & Amaral, T., 10.2023, In: ESMO OPEN. 8, 5, p. 101625

    Research output: SCORING: Contribution to journalEditorialResearch

  6. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry

    Riecke, K., Müller, V., Neunhöffer, T., Park-Simon, T-W., Weide, R., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Wuerstlein, R., Denkert, C., Decker, T., Fehm, T., Nekljudova, V., Rey, J., Loibl, S., Laakmann, E. & Witzel, I., 06.2023, In: ESMO OPEN. 8, 3, p. 101213

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Systemic treatment of metastatic hormone-sensitive prostate cancer-upfront triplet versus doublet combination therapy

    Oing, C. & Bristow, R. G., 04.2023, In: ESMO OPEN. 8, 2, p. 101194

    Research output: SCORING: Contribution to journalEditorialResearch

  8. 2022
  9. Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial

    Harnischfeger, N., Rath, H. M., Alt-Epping, B., Brand, H., Haller, K., Letsch, A., Rieder, N., Thuss-Patience, P., Bokemeyer, C., Bergelt, C. & Oechsle, K., 01.12.2022, In: ESMO OPEN. 7, 6, 100623.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)

    Schmidt, M., Lübbe, K., Decker, T., Thill, M., Bauer, L., Müller, V., Link, T., Furlanetto, J., Reinisch, M., Mundhenke, C., Hoffmann, O., Zahn, M-O., Müller, L., Denkert, C., van Mackelenbergh, M., Fasching, P. A., Burchardi, N., Nekljudova, V. & Loibl, S., 12.2022, In: ESMO OPEN. 7, 6, 100601.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. The current role of precision surgery in oligometastatic prostate cancer

    von Deimling, M., Rajwa, P., Tilki, D., Heidenreich, A., Pallauf, M., Bianchi, A., Yanagisawa, T., Kawada, T., Karakiewicz, P. I., Gontero, P., Pradere, B., Ploussard, G., Rink, M. & Shariat, S. F., 12.2022, In: ESMO OPEN. 7, 6, p. 100597 100597.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  12. Methylation subgroup and molecular heterogeneity is a hallmark of glioblastoma: implications for biopsy targeting, classification and therapy

    Gempt, J., Withake, F., Aftahy, A. K., Meyer, H. S., Barz, M., Delbridge, C., Liesche-Starnecker, F., Prokop, G., Pfarr, N., Schlegel, J., Meyer, B., Zimmer, C., Menze, B. H. & Wiestler, B., 10.2022, In: ESMO OPEN. 7, 5, p. 100566

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Multimodal survival prediction in advanced pancreatic cancer using machine learning

    Keyl, J., Kasper, S., Wiesweg, M., Götze, J., Schönrock, M., Sinn, M., Berger, A., Nasca, E., Kostbade, K., Schumacher, B., Markus, P., Albers, D., Treckmann, J., Schmid, K. W., Schildhaus, H-U., Siveke, J. T., Schuler, M. & Kleesiek, J., 10.2022, In: ESMO OPEN. 7, 5, 100555.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

    Hartlapp, I., Valta-Seufzer, D., Siveke, J. T., Algül, H., Goekkurt, E., Siegler, G., Martens, U. M., Waldschmidt, D., Pelzer, U., Fuchs, M., Kullmann, F., Boeck, S., Ettrich, T. J., Held, S., Keller, R., Anger, F., Germer, C. T., Stang, A., Kimmel, B., Heinemann, V., Kunzmann, V. & German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators, 08.2022, In: ESMO OPEN. 7, 4, p. 100552

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Assessment of the management of carcinomatous meningitis from breast cancer globally: a study by the Breast International Group Brain Metastasis Task Force

    Razis, E., Escudero, M. J., Palmieri, C., Mueller, V., Bartsch, R., Rossi, G., Gampenrieder, S. P., Kolberg, H. C., Zdenkowski, N., Pavic, M., Connolly, R. M., Rosset, L., Arcuri, J., Tesch, H., Vallejos, C., Retamales, J., Musolino, A., Del Mastro, L., Christodoulou, C., Aebi, S., Paluch-Shimon, S., Gupta, S., Ohno, S., Macpherson, I., Ekholm, M., Zaman, K., Vidal, M., Chakiba, C., Fumagalli, D., Thulin, A., Witzel, I., Kotecki, N., Gil-Gil, M. & Linderholm, B., 06.2022, In: ESMO OPEN. 7, 3, 100483.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry

    Laakmann, E., Witzel, I., Neunhöffer, T., Park-Simon, T-W., Weide, R., Riecke, K., Polasik, A., Schmidt, M., Puppe, J., Mundhenke, C., Lübbe, K., Hesse, T., Thill, M., Zahm, D-M., Denkert, C., Fehm, T., Nekljudova, V., Rey, J., Loibl, S. & Müller, V., 06.2022, In: ESMO OPEN. 7, 3, 100495.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors

    Ochsenreither, S., Fiedler, W. M., Conte, G. D., Macchini, M., Matos, I., Habel, B., Ahrens-Fath, I., Raspagliesi, F., Lorusso, D., Keilholz, U., Rolling, C., Kebenko, M., Klinghammer, K. F., Saavedra, O., Baumeister, H., Zurlo, A. & Garralda, E., 06.04.2022, In: ESMO OPEN. 7, 2, 100447.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus

    Buske, C., Dreyling, M., Alvarez-Larrán, A., Apperley, J., Arcaini, L., Besson, C., Bullinger, L., Corradini, P., Giovanni Della Porta, M., Dimopoulos, M., D'Sa, S., Eich, H. T., Foà, R., Ghia, P., da Silva, M. G., Gribben, J., Hajek, R., Harrison, C., Heuser, M., Kiesewetter, B., Kiladjian, J. J., Kröger, N., Moreau, P., Passweg, J. R., Peyvandi, F., Rea, D., Ribera, J-M., Robak, T., San-Miguel, J. F., Santini, V., Sanz, G., Sonneveld, P., von Lilienfeld-Toal, M., Wendtner, C., Pentheroudakis, G. & Passamonti, F., 04.2022, In: ESMO OPEN. 7, 2, 100403.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. The impact of COVID-19 on oncology professionals-one year on: lessons learned from the ESMO Resilience Task Force survey series

    Lim, K. H. J., Murali, K., Thorne, E., Punie, K., Kamposioras, K., Oing, C., O'Connor, M., Élez, E., Amaral, T., Garrido, P., Lambertini, M., Devnani, B., Westphalen, C. B., Morgan, G., Haanen, J. B. A. G., Hardy, C. & Banerjee, S., 02.2022, In: ESMO OPEN. 7, 1, 100374.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2021
  21. Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program

    Müller, V., Banys-Paluchowski, M., Friedl, T. W. P., Fasching, P. A., Schneeweiss, A., Hartkopf, A., Wallwiener, D., Rack, B., Meier-Stiegen, F., Huober, J., Rübner, M., Hoffmann, O., Müller, L., Janni, W., Wimberger, P., Jäger, B., Pantel, K., Riethdorf, S., Harbeck, N., Fehm, T. & DETECT Study Group, 12.2021, In: ESMO OPEN. 6, 6, 100299.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I study

    Bordonaro, R., Calvo, A., Auriemma, A., Hollebecque, A., Rubovszky, G., Saunders, M. P., Pápai, Z., Prager, G., Stein, A., André, T., Argilés, G., Cubillo, A., Dahan, L., Edeline, J., Leger, C., Cattan, V., Fougeray, R., Amellal, N. & Tabernero, J., 10.2021, In: ESMO OPEN. 6, 5, 100270.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II

    Lim, K. H. J., Murali, K., Kamposioras, K., Punie, K., Oing, C., O'Connor, M., Thorne, E., Amaral, T., Garrido, P., Lambertini, M., Devnani, B., Westphalen, C. B., Morgan, G., Haanen, J. B. A. G., Hardy, C. & Banerjee, S., 08.2021, In: ESMO OPEN. 6, 4, p. 100199

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

    Banerjee, S., Lim, K. H. J., Murali, K., Kamposioras, K., Punie, K., Oing, C., O'Connor, M., Thorne, E., Devnani, B., Lambertini, M., Westphalen, C. B., Garrido, P., Amaral, T., Morgan, G., Haanen, J. B. A. G. & Hardy, C., 04.2021, In: ESMO OPEN. 6, 2, 100058.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Supportive care in patients with cancer during the COVID-19 pandemic

    Aapro, M., Lyman, G. H., Bokemeyer, C., Rapoport, B. L., Mathieson, N., Koptelova, N., Cornes, P., Anderson, R., Gascón, P. & Kuderer, N. M., 02.2021, In: ESMO OPEN. 6, 1, p. 100038

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  26. 2020
  27. Oncological care organisation during COVID-19 outbreak

    Onesti, C. E., Rugo, H. S., Generali, D., Peeters, M., Zaman, K., Wildiers, H., Harbeck, N., Martin, M., Cristofanilli, M., Cortes, J., Tjan-Heijnen, V., Hurvitz, S. A., Berchem, G., Tagliamento, M., Campone, M., Bartsch, R., De Placido, S., Puglisi, F., Rottey, S., Müller, V., Ruhstaller, T., Machiels, J-P., Conte, P., Awada, A. & Jerusalem, G., 08.2020, In: ESMO OPEN. 5, 4

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. 2019
  29. Awareness of predatory journals and open access among medical oncologists: results of an online survey

    Richtig, G., Richtig, E., Böhm, A., Oing, C., Bozorgmehr, F., Kruger, S., Kiesewetter, B., Zielinski, C. & Berghoff, A. S., 2019, In: ESMO OPEN. 4, 6, p. e000580

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Flucelvax Tetra: a surface antigen, inactivated, influenza vaccine prepared in cell cultures

    Bühler, S. & Ramharter, M., 2019, In: ESMO OPEN. 4, 1, p. e000481

    Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

  31. 2018
  32. Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas

    Fiedler, W., Cresta, S., Schulze-Bergkamen, H., De Dosso, S., Weidmann, J., Tessari, A., Baumeister, H., Danielczyk, A., Dietrich, B., Goletz, S., Zurlo, A., Salzberg, M., Sessa, C. & Gianni, L., 2018, In: ESMO OPEN. 3, 2, p. e000303

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Phase I study of TrasGEX, a glyco-optimised anti-HER2 monoclonal antibody, in patients with HER2-positive solid tumours

    Fiedler, W., Stoeger, H., Perotti, A., Gastl, G., Weidmann, J., Dietrich, B., Baumeister, H., Danielczyk, A., Goletz, S., Salzberg, M. & De Dosso, S., 2018, In: ESMO OPEN. 3, 4, p. e000381

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review